The FDA expanded the age range for EndeavorRx — the prescription video game treatment for ADHD — to include adolescents ages 13 to 17, maker Akili said. It was previously approved for kids ages 8 to 12.
A new Milliman report suggested that most Americans with mental health conditions don’t get treatment.
A non-invasive spinal cord stimulation treatment improved symptoms of major depressive disorder in a small trial. (Molecular Psychiatry)
Michael Stone, MD, a psychiatrist who studied evil, died at the age of 90, and pioneering transgender psychiatrist Jeanne Hoff, MD, died at age 85. (New York Times)
Gen Z is suffering from a new type of stress: menu anxiety. (New York Post)
A federal judge barred expert witnesses from testifying that acetaminophen (Tylenol) can cause autism or ADHD if mothers take it during pregnancy, citing a lack of scientific support for the claims. (Reuters)
Full results of the phase III EMERGENT-2 trial testing the dual M1/M4 muscarinic receptor agonist xanomeline-trospium (KarXT) for schizophrenia were published in The Lancet. First presented at Psych Congress in 2022, developer Karuna Therapeutics said the FDA will make a regulatory decision by September 2024.
About 28% of Americans said they’re making a New Year’s resolution focused on mental health, according to an American Psychiatric Association poll.
“Trip killers” — benzodiazepines or antipsychotics that people take to end a bad psychedelic drug trip — are a challenge for emergency physicians. (Emergency Medicine Journal)
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/kristenMonaco_188.jpg)
Please enable JavaScript to view the